• Profile
Close

Adiposity and estrogen receptor-positive, postmenopausal breast cancer risk: Quantification of the mediating effects of fasting insulin and free estradiol

International Journal of Cancer Jan 29, 2020

Dashti SG, Simpson JA, Karahalios A, et al. - Given an increased risk of estrogen receptor (ER)-positive postmenopausal breast cancer is seen in relation to the presence of adiposity, researchers quantified mediating influences of fasting insulin and free estradiol in the adiposity and ER-positive postmenopausal breast cancer link. For this purpose, they utilized data from a case–cohort investigation of sex hormones and insulin signaling nested within the Melbourne Collaborative Cohort Study. There were 149 cases and 1,029 controls. The risk ratio of breast cancer was estimated to be 1.75 for women with BMI > 30 kg/m2 vs women with BMI 18.5–25 kg/m2. The percentage mediated effect through free estradiol was estimated to be 72%. For an indirect influence through insulin, no evidence was found. A crucial mediating role of circulating free estradiol in the adiposity–breast cancer link was suggested, however, circulating free estradiol did not explain all of the association.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay